How a tightening labor market impacts Biotech and Pharma Manufacturing
Labor market in Biotech and Pharma With the latest release of employment data from the U.S. Labor Department, it is apparent that, at least in
Labor market in Biotech and Pharma With the latest release of employment data from the U.S. Labor Department, it is apparent that, at least in
Being responsible for a new product launch in biotech is arguably one of the hardest tasks, with most of the focus directed towards the Go-To-Market
Choosing the right biotech contract manufacturer to partner with is critical for your business success. Get it right, and a good contract manufacturer relationship gives
Foundry Model Part Three – Increasing Cost of Innovation The third driver that is triggering the growth of the foundry model in Molecular Diagnostics is
Foundry Model Part Two- Leveraging Commonality The second driver that spawned the growth of the foundry model was the ability to Leverage Commonality. By the
Foundry Model Part One – Keeping Pace in Molecular Diagnostics Innovation The foundry model is poised to fundamentally transform the biotechnology and molecular diagnostics sectors.
Variabilization- Turn Fixed Cost Into Variable Cost The concept of variabilization, a willful shift from fixed to variable costs, has been around since the late
Let’s Talk! Join The Argonauts at AACC at Booth #2020 on Tuesday, August 1st from 3:30pm to 5:00pm for food and craft beers and learn how
This animated video explains how biotech and diagnostic companies can reduce manufacturing risk while getting to market faster. The manufacturing journey doesn’t have to be
Common Biotech Supply Chain Errors As operations and manufacturing professionals, we understand the standard supply chain errors such as running too lean, lack of transparency